Neoadjuvant Lenvatinib Combined With Letrozole in Hormone Receptor Positive Breast Cancer
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Lenvatinib + Letrozole
Sponsor: National University Hospital, Singapore
Collaborators: Eisai Co., Ltd.